Clinical trials
Phase 1/2 Glioblastoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
187 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 12 |
| 2001 | 4 |
| 2002 | 7 |
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 6 |
| 2006 | 8 |
| 2007 | 7 |
| 2008 | 4 |
| 2009 | 7 |
| 2010 | 11 |
| 2011 | 7 |
| 2012 | 8 |
| 2013 | 9 |
| 2014 | 6 |
| 2015 | 4 |
| 2016 | 10 |
| 2017 | 9 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 9 |
| 2021 | 6 |
| 2022 | 5 |
| 2023 | 10 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 95 |
| Recruiting | 28 |
| Terminated | 28 |
| Active, not recruiting | 16 |
| Unknown status | 10 |
| Not yet recruiting | 6 |
| Suspended | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 24 |
| M.D. Anderson Cancer Center | 8 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 8 |
| New Approaches to Brain Tumor Therapy Consortium | 7 |
| Northwell Health | 6 |
| Novartis Pharmaceuticals | 4 |
| Duke University | 3 |
| Eli Lilly and Company | 3 |
| Jonsson Comprehensive Cancer Center | 3 |
| Radiation Therapy Oncology Group | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 187 |
| Brain Neoplasms | 78 |
| Gliosarcoma | 72 |
| Astrocytoma | 53 |
| Glioma | 52 |
| Central Nervous System Neoplasms | 41 |
| Oligodendroglioma | 31 |
| Neoplasms | 14 |
| Carcinoma, Non-Small-Cell Lung | 11 |
| Recurrence | 10 |
Trials
Showing 1 to 25 of 187. Each trial links to its page on Pharma Observatory.
87 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.